Philip A. Serlin
CIK: 0001493277
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLRX
BioLineRx Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
Philip A. Serlin files insider reports with the SEC as Chief Executive Officer of BioLineRx Ltd. (BLRX).
About Serlin Philip A
Serlin Philip A (SEC CIK 0001493277) files insider reports with the SEC as Chief Executive Officer of BioLineRx Ltd. (BLRX).
Signal8 holds 1 ownership filing by Serlin Philip A, a Form 3, filed on Mar 27, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Serlin Philip A's filings is in MODII'N.
Other insiders filing for BioLineRx Ltd. (BLRX)
- Yan Shaoyu, Director
- Cohen Gal Avraham, Director
- Schwartz Aharon, Director
- Zeevi Mali, Chief Financial Officer
- BORMANN-KENNEDY BARBARA-JEAN ANNE, Director